Jason Denbo, MD

Assistant Professor
Division of Surgical Oncology,

Jason Denbo

Contact Info

denbo007@umn.edu

Office Phone 612-625-2991

Fax 612-625-4406

Mailing Address:
420 Delaware Street SE
MMC 195
Minneapolis, MN 55455

Administrative Assistant Name
Stephanie Lundgren

Administrative Phone
612-625-2991

Administrative Email
smlundgr@umn.edu

Administrative Fax Number
612-625-4406

Assistant Professor
Division of Surgical Oncology


MD, Indiana University School of Medicine, Indianapolis, IN

General Surgery Residency, University of Tennessee Health Science Center, Memphis, TN

Complex General Surgical Oncology Fellowship, University of Texas MD Anderson Cancer Center, Houston, TX

Hepatopancreatobiliary Surgery Fellowship, University of Texas MD Anderson Cancer Center, Houston, TX; Research Fellowship, St. Jude Children’s Research Hospital, Memphis, TN.

Summary

Pancreas, liver, and stomach cancers are complex life-altering problems for patients and their families. I believe all cancer patients deserve a cohesive, multi-specialty, patient-centered care plan that is executed by a compassionate group of care providers. I am honored to be a part of such a group at the University of Minnesota, and privileged to care for our patients in their time of great need

Expertise

  • Surgical Oncology
  • Hepatopancreatobiliary Surgery

Awards & Recognition

  • Chief Resident Teaching Award (2013-2014), University of Tennessee Health Science Center, Memphis, TN.
  • Clinical Excellence Award (2015-2016), University of Texas MD Anderson Cancer Center, Houston, TX.
  • Appreciation Award for Promoting Excellence in Patient Care (2015-2016), University of Texas MD Anderson Cancer Center, Houston, TX.

Professional Associations

  • Society of Surgical Oncology
  • AHPBA
  • IHPBA
  • Pancreas Club
  • SSAT

Research

Research Summary/Interests

Pancreatic cancer – clinical care pathways, multimodality therapy (chemotherapy, radiation, and surgery), and patient reported outcomes. Colorectal liver metastases – multimodality therapy (chemotherapy, liver directed/ablative therapy, and surgery), and the impact of genetic mutations.

Clinical

Board Certifications

  • The American Board of Surgery, General Surgery
  • The American Board of Surgery, Complex General Surgical Oncology
  • The American Board of Medical Quality

Clinical Interests

Malignant diseases of liver, bile ducts, and pancreas – including hepatocellular carcinoma, colorectal liver metastases, cholangiocarcinoma, and pancreatic adenocarcinoma; gastrointestinal and pancreatic neuroendocrine tumors; gastric